Alnylam Canada ULC is pleased to announce it has received a positive recommendation from Canada's Drug Agency (CDA) for the public reimbursement of its RNAi therapeutic, AMVUTTRA®.1 In December 2025, ...
The way we listen to music has changed dramatically over the past two decades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results